| scholarly article | Q13442814 |
| P2093 | author name string | Levy NS | |
| Levy AP | |||
| Goldberg MA | |||
| Wegner S | |||
| P433 | issue | 22 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hypoxia | Q105688 |
| endothelium | Q111140 | ||
| P304 | page(s) | 13333-13340 | |
| P577 | publication date | 1995-06-01 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia | |
| P478 | volume | 270 |
| Q34113282 | A 40-bp RNA element that mediates stabilization of vascular endothelial growth factor mRNA by HuR. |
| Q26772837 | A Review of the Mechanisms of Blood-Brain Barrier Permeability by Tissue-Type Plasminogen Activator Treatment for Cerebral Ischemia |
| Q35925759 | A cytokine mRNA-destabilizing element that is structurally and functionally distinct from A+U-rich elements. |
| Q30409365 | A miR-297/hypoxia/DGK-α axis regulating glioblastoma survival |
| Q35791570 | A molecular description of brain trauma pathophysiology using microarray technology: an overview |
| Q38526996 | A new biological strategy for high productivity of recombinant proteins in animal cells by the use of hypoxia-response enhancer |
| Q24681396 | A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1alpha regulates the VEGF expression and is potentially involved in lung and vascular development |
| Q28585565 | A novel mechanism of repression of the vascular endothelial growth factor promoter, by single strand DNA binding cold shock domain (Y-box) proteins in normoxic fibroblasts |
| Q35930789 | A pharmacological investigation of Hippophae salicifolia (HS) and Hippophae rhamnoides turkestanica (HRT) against multiple stress (C-H-R): an experimental study using rat model |
| Q43000212 | A precursor form of vascular endothelial growth factor arises by initiation from an upstream in-frame CUG codon |
| Q28587042 | A zinc-finger protein, PLAGL2, induces the expression of a proapoptotic protein Nip3, leading to cellular apoptosis |
| Q36524561 | AAV vector encoding human VEGF165-transduced pectineus muscular flaps increase the formation of new tissue through induction of angiogenesis in an in vivo chamber for tissue engineering: A technique to enhance tissue and vessels in microsurgically e |
| Q42125573 | Ablation of 4E-BP1/2 prevents hyperglycemia-mediated induction of VEGF expression in the rodent retina and in Muller cells in culture |
| Q35574943 | Acacetin inhibits VEGF expression, tumor angiogenesis and growth through AKT/HIF-1α pathway |
| Q39651490 | Activated STAT3 Regulates Hypoxia-Induced Angiogenesis and Cell Migration in Human Glioblastoma |
| Q57377936 | Activation of Hypoxia-inducible Factor-1; Definition of Regulatory Domains within the α Subunit |
| Q24316075 | Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1 |
| Q38341890 | Activator-protein-1 binding potentiates the hypoxia-induciblefactor-1-mediated hypoxia-induced transcriptional activation of vascular-endothelial growth factor expression in C6 glioma cells |
| Q47952081 | Adaptive hypoxic tolerance in the subterranean mole rat Spalax ehrenbergi: the role of vascular endothelial growth factor |
| Q34035800 | Adeno-associated viral vector-mediated hypoxia response element-regulated gene expression in mouse ischemic heart model |
| Q48443195 | Alterations in GLUT1 and GLUT3 glucose transporter gene expression following unilateral hypoxia-ischemia in the immature rat brain |
| Q61795922 | Altered VEGF Splicing Isoform Balance in Tumor Endothelium Involves Activation of Splicing Factors Srpk1 and Srsf1 by the Wilms' Tumor Suppressor Wt1 |
| Q34630891 | Alternative poly(A) site selection in complex transcription units: means to an end? |
| Q46064052 | Alveolar hypoxia increases gene expression of extracellular matrix proteins and platelet-derived growth factor-B in lung parenchyma |
| Q33553393 | Amyotrophic lateral sclerosis-linked mutant SOD1 sequesters Hu antigen R (HuR) and TIA-1-related protein (TIAR): implications for impaired post-transcriptional regulation of vascular endothelial growth factor |
| Q28678439 | An essential role for p300/CBP in the cellular response to hypoxia |
| Q34611616 | An overview of small-molecule inhibitors of VEGFR signaling |
| Q45861315 | Analysis of signal transduction pathways in macrophages using expression vectors with CMV promoters: a cautionary tale |
| Q38086359 | Angiogenesis and hypoxia in the kidney |
| Q34276799 | Angiogenesis and leukemia |
| Q73129425 | Angiogenesis and metastasis |
| Q42164955 | Angiogenesis and myogenesis as two facets of inflammatory post-ischemic tissue regeneration |
| Q35789199 | Angiogenesis and vascular architecture in pheochromocytomas: distinctive traits in malignant tumors |
| Q37534974 | Angiogenesis drives psoriasis pathogenesis |
| Q55472560 | Angiogenesis factors in gliomas: a new key to tumour therapy? |
| Q34132821 | Angiogenesis: the role of the microenvironment in flipping the switch. |
| Q39763075 | Anti-tumor activity and mechanisms of a novel vascular disrupting agent, (Z)-3,4',5-trimethoxylstilbene-3'-O-phosphate disodium (M410). |
| Q35683322 | Association of the von Hippel-Lindau protein with AUF1 and posttranscriptional regulation of VEGFA mRNA. |
| Q57099477 | Associations between vascular endothelial growth factor gene polymorphisms and susceptibility to acute mountain sickness |
| Q46356930 | Attenuation of the exercise-induced increase in skeletal muscle Flt-1 mRNA by nitric oxide synthase inhibition |
| Q36799838 | Autocrine VEGF loops, signaling pathways, and acute leukemia regulation. |
| Q47815539 | BRG1 promotes VEGF-A expression and angiogenesis in human colorectal cancer cells |
| Q35019038 | Basic principles of angiogenesis for the interventional cardiologist |
| Q28201923 | Beta-catenin inversely regulates vascular endothelial growth factor-D mRNA stability |
| Q38298694 | Blockade of NF-kappaB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis |
| Q43755773 | Blood-retinal barrier breakdown in experimental coronavirus retinopathy: association with viral antigen, inflammation, and VEGF in sensitive and resistant strains |
| Q39123134 | Bovine immature oocytes acquire developmental competence during meiotic arrest in vitro |
| Q26826870 | Brain homeostasis: VEGF receptor 1 and 2-two unequal brothers in mind |
| Q33603639 | Candesartan induces a prolonged proangiogenic effect and augments endothelium-mediated neuroprotection after oxygen and glucose deprivation: role of vascular endothelial growth factors A and B. |
| Q45263616 | Capillary supply and gene expression of angiogenesis-related factors in murine skeletal muscle following denervation |
| Q33702514 | Cells depleted of mitochondrial DNA (rho0) yield insight into physiological mechanisms |
| Q28259513 | Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha |
| Q41137025 | Characterization of a soluble vascular endothelial growth factor receptor-immunoglobulin chimera |
| Q24314336 | Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2 |
| Q24652148 | Chordin-like 1, a bone morphogenetic protein-4 antagonist, is upregulated by hypoxia in human retinal pericytes and plays a role in regulating angiogenesis |
| Q46633975 | Chronic hypoxia attenuates resting and exercise-induced VEGF, flt-1, and flk-1 mRNA levels in skeletal muscle |
| Q44146774 | Ciclopirox prevents peroxynitrite toxicity in astrocytes by maintaining their mitochondrial function: a novel mechanism for cytoprotection by ciclopirox |
| Q46014175 | Clinical response to therapy targeted at vascular endothelial growth factor in metastatic renal cell carcinoma: impact of patient characteristics and Von Hippel-Lindau gene status. |
| Q46230317 | Cobalt chloride decreases EC-SOD expression through intracellular ROS generation and p38-MAPK pathways in COS7 cells |
| Q38300747 | Cobalt induces heme oxygenase-1 expression by a hypoxia-inducible factor-independent mechanism in Chinese hamster ovary cells: regulation by Nrf2 and MafG transcription factors |
| Q90625326 | Combining in silico and in vitro models to inform cell seeding strategies in tissue engineering |
| Q33558362 | Competitive binding between Seryl-tRNA synthetase/YY1 complex and NFKB1 at the distal segment results in differential regulation of human vegfa promoter activity during angiogenesis |
| Q51895792 | Competitive enhancement of HGF-induced epithelial scattering by accessory growth factors |
| Q42816271 | Constitutive activation of Stat3alpha in brain tumors: localization to tumor endothelial cells and activation by the endothelial tyrosine kinase receptor (VEGFR-2). |
| Q74296792 | Coordinated Up-regulation by hypoxia of adrenomedullin and one of its putative receptors (RDC-1) in cells of the rat blood-brain barrier |
| Q43873087 | Corneal epithelial VEGF and cytochrome P450 4B1 expression in a rabbit model of closed eye contact lens wear |
| Q35764703 | Correlation of high lactate levels in head and neck tumors with incidence of metastasis |
| Q35763195 | Cross Talk between Proliferative, Angiogenic, and Cellular Mechanisms Orchestred by HIF-1α in Psoriasis |
| Q40629309 | Cyclin dependent kinase inhibitor p27Kip1 is upregulated by hypoxia via an ARNT dependent pathway |
| Q34145860 | Cytosolic Phospholipase A2 and Lysophospholipids in Tumor Angiogenesis |
| Q40689319 | Cytosolic phospholipase A2: targeting cancer through the tumor vasculature |
| Q53697954 | Daily muscle stretching enhances blood flow, endothelial function, capillarity, vascular volume and connectivity in aged skeletal muscle. |
| Q28510984 | Defective vascularization of HIF-1alpha-null embryos is not associated with VEGF deficiency but with mesenchymal cell death |
| Q33746851 | Detection of RTP801, a gene that is differentially expressed in irradiated HeLa cells |
| Q38542115 | Diabetic Retinopathy: Vascular and Inflammatory Disease. |
| Q50518904 | Differences in capillary architecture, hemodynamics, and angiogenic factors in rat slow and fast plantarflexor muscles. |
| Q54586398 | Different vascular endothelial growth factor (VEGF), VEGF-receptor 1 and -2 mRNA expression profiles between clear cell and papillary renal cell carcinoma. |
| Q37486496 | Differential regulation of HIF-1alpha isoforms in murine macrophages by TLR4 and adenosine A(2A) receptor agonists. |
| Q28282227 | Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1 |
| Q28582266 | Distinct protein kinase C isoforms mediate regulation of vascular endothelial growth factor expression by A2A adenosine receptor activation and phorbol esters in pheochromocytoma PC12 cells |
| Q30631779 | Dramatic inhibition of retinal and choroidal neovascularization by oral administration of a kinase inhibitor |
| Q41193001 | Drosophila melanogaster SL2 cells contain a hypoxically inducible DNA binding complex which recognises mammalian HIF-binding sites |
| Q39456277 | Dual action of a selective cyclooxygenase-2 inhibitor on vascular endothelial growth factor expression in human hepatocellular carcinoma cells: novel involvement of discoidin domain receptor 2. |
| Q35362327 | Dual mechanism of vascular endothelial growth factor upregulation by hypoxia in human hepatocellular carcinoma |
| Q46429411 | Dynamic production of hypoxia-inducible factor-1alpha in early transplanted islets |
| Q73383441 | Dynamics of tumor oxygenation, CD31 staining and transforming growth factor-beta levels after treatment with radiation or cyclophosphamide in the rat 13762 mammary carcinoma |
| Q54603104 | ER stress inducer, thapsigargin, decreases extracellular-superoxide dismutase through MEK/ERK signalling cascades in COS7 cells. |
| Q35764829 | Early events of metastasis in the microcirculation involve changes in gene expression of cancer cells. Tracking mRNA levels of metastasizing cancer cells in the chick embryo chorioallantoic membrane. |
| Q41734131 | Effect of captopril on skeletal muscle angiogenic growth factor responses to exercise |
| Q33723780 | Effect of inflammatory cytokines on the expression of the vascular endothelial growth factor-C. |
| Q36005858 | Effects of androgen suppression and radiation on prostate cancer suggest a role for angiogenesis blockade. |
| Q30405663 | Effects of prenatal hypoxia on schizophrenia-related phenotypes in heterozygous reeler mice: a gene × environment interaction study |
| Q44614679 | Effects of transcutaneous topical injection of oxygen on vascular endothelial growth factor gene into the healing ligament in rats |
| Q34722259 | Endothelin-1 as a target for therapeutic intervention in prostate cancer |
| Q36977680 | Epoxyeicosatrienoic acids are part of the VEGF-activated signaling cascade leading to angiogenesis. |
| Q43179970 | Exogenous expression of HIF-1 alpha promotes cardiac differentiation of embryonic stem cells |
| Q39778145 | Expansion of human SCID-repopulating cells under hypoxic conditions |
| Q55474992 | Expression and regulation of neuropilin-1 in human astrocytomas. |
| Q42492388 | Expression of angiogenic regulators and skeletal muscle capillarity in selectively bred high aerobic capacity mice |
| Q78010550 | Expression of human fibroblast growth factor 2 mRNA is post-transcriptionally controlled by a unique destabilizing element present in the 3'-untranslated region between alternative polyadenylation sites |
| Q35011429 | Expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor in hepatocellular carcinoma: Impact on neovascularization and survival |
| Q36311170 | Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in tumor angiogenesis and malignancies |
| Q30702404 | Expression of vascular endothelial growth factor and its receptor (KDR/flk-1) mRNA in experimental choroidal neovascularization |
| Q77658822 | Expression of vascular endothelial growth factor and its receptor, KDR, following retinal ischemia-reperfusion injury in the rat |
| Q35587630 | Expression of vascular endothelial growth factor, hypoxia inducible factor 1alpha, and carbonic anhydrase IX in human tumours |
| Q37469123 | Factors interacting with HIF-1alpha mRNA: novel therapeutic targets |
| Q36256017 | Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesis |
| Q37003673 | FoxM1B transcriptionally regulates vascular endothelial growth factor expression and promotes the angiogenesis and growth of glioma cells |
| Q36562473 | Functional interference between hypoxia and dioxin signal transduction pathways: competition for recruitment of the Arnt transcription factor |
| Q38235326 | Functional polymers of gene delivery for treatment of myocardial infarct |
| Q22008661 | Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1 |
| Q38633855 | Gelatin-Based Hydrogels Promote Chondrogenic Differentiation of Human Adipose Tissue-Derived Mesenchymal Stem Cells In Vitro |
| Q37670272 | Gender differences in hypoxic acclimatization in cyclooxygenase-2-deficient mice |
| Q42378908 | Gene delivery of hypoxia-inducible VEGF targeting collagen effectively improves cardiac function after myocardial infarction |
| Q40412645 | Gene expression profiling of hypoxia signaling in human hepatocellular carcinoma cells |
| Q37658736 | Gene regulation and molecular toxicology |
| Q57109264 | Genetic variation in hypoxia-inducible factor 1alpha and its possible association with high altitude adaptation in Sherpas |
| Q36884488 | Genomic organization of human and mouse genes for vascular endothelial growth factor C. |
| Q28067399 | Glioblastoma, hypoxia and autophagy: a survival-prone 'ménage-à-trois' |
| Q40473451 | Glucose deprivation increases mRNA stability of vascular endothelial growth factor through activation of AMP-activated protein kinase in DU145 prostate carcinoma. |
| Q40026307 | Graded hypoxia modulates the invasive potential of HT1080 fibrosarcoma and MDA MB231 carcinoma cells |
| Q37383757 | Growth factor activation of the estrogen receptor in vascular cells occurs via a mitogen-activated protein kinase-independent pathway |
| Q28588778 | HIF-1 alpha is required for solid tumor formation and embryonic vascularization. |
| Q37988265 | HIF-1 versus HIF-2--is one more important than the other? |
| Q40655023 | HIF-1α mRNA and protein upregulation involves Rho GTPase expression during hypoxia in renal cell carcinoma |
| Q44404818 | HIF-2α regulates glyceraldehyde-3-phosphate dehydrogenase expression in endothelial cells |
| Q35915111 | HIF1α is necessary for exercise-induced neuroprotection while HIF2α is needed for dopaminergic neuron survival in the substantia nigra pars compacta |
| Q38066120 | HIFs, angiogenesis, and cancer |
| Q35937574 | HIFs, hypoxia, and vascular development |
| Q34537034 | Heme oxygenase-1/carbon monoxide induces vascular endothelial growth factor expression via p38 kinase-dependent activation of Sp1 |
| Q38668174 | Hepatic metastatic niche: from normal to pre-metastatic and metastatic niche. |
| Q44509761 | Hepatitis B virus X protein enhances transcriptional activity of hypoxia-inducible factor-1alpha through activation of mitogen-activated protein kinase pathway |
| Q35788316 | Hepatocellular hypoxia-induced vascular endothelial growth factor expression and angiogenesis in experimental biliary cirrhosis |
| Q35584931 | High altitude hypoxia: an intricate interplay of oxygen responsive macroevents and micromolecules |
| Q40813221 | Hydrogen peroxide stimulates macrophage vascular endothelial growth factor release |
| Q36653195 | Hyperbaric oxygen therapy for malignancy: a review. |
| Q43546852 | Hypoxia activates Akt and induces phosphorylation of GSK-3 in PC12 cells |
| Q58207713 | Hypoxia and endothelin-1 induce VEGF production in human vascular smooth muscle cells |
| Q53605066 | Hypoxia and expression of hypoxia-inducible factor in the aging kidney. |
| Q42274707 | Hypoxia and mitochondrial inhibitors regulate expression of glucose transporter-1 via distinct Cis-acting sequences |
| Q41759020 | Hypoxia and the regulation of gene expression |
| Q38460725 | Hypoxia downregulates tropoelastin gene expression in rat lung fibroblasts by pretranslational mechanisms |
| Q35103473 | Hypoxia in renal disease with proteinuria and/or glomerular hypertension |
| Q38351071 | Hypoxia induces apoptosis in SV40-immortalized rat proximal tubular cells through the mitochondrial pathways, devoid of HIF1-mediated upregulation of Bax. |
| Q28263501 | Hypoxia induces type II NOS gene expression in pulmonary artery endothelial cells via HIF-1 |
| Q38097867 | Hypoxia inducible factor pathway inhibitors as anticancer therapeutics. |
| Q37665438 | Hypoxia inducible factor-1 mediates the expression of the immune checkpoint HLA-G in glioma cells through hypoxia response element located in exon 2. |
| Q38685135 | Hypoxia inducible factors in hepatocellular carcinoma |
| Q52864076 | Hypoxia inhibits nephrogenesis through paracrine Vegfa despite the ability to enhance tubulogenesis. |
| Q36817483 | Hypoxia is important in F‑18 FDG accumulation in thecoma‑fibroma tumors on F‑18 FDG PET/CT scans |
| Q28202069 | Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene |
| Q40671269 | Hypoxia up-regulates glyceraldehyde-3-phosphate dehydrogenase in mouse brain capillary endothelial cells: involvement of Na+/Ca2+ exchanger |
| Q44176981 | Hypoxia upregulates VEGF expression in alveolar epithelial cells in vitro and in vivo |
| Q33924693 | Hypoxia, clonal selection, and the role of HIF-1 in tumor progression |
| Q73074009 | Hypoxia-induced VEGF enhances tumor survivability via suppression of serum deprivation-induced apoptosis |
| Q36137705 | Hypoxia-induced angiogenesis: good and evil |
| Q31012200 | Hypoxia-induced regulation of MAPK phosphatase-1 as identified by subtractive suppression hybridization and cDNA microarray analysis |
| Q28572018 | Hypoxia-induced upregulation of pigment epithelium-derived factor by retinal glial (Müller) cells |
| Q35809808 | Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia |
| Q63565690 | Hypoxia-inducible Factor-1 Mediates Transcriptional Activation of the Heme Oxygenase-1 Gene in Response to Hypoxia |
| Q45864532 | Hypoxia-inducible VEGF gene delivery to ischemic myocardium using water-soluble lipopolymer |
| Q47795280 | Hypoxia-inducible factor 1: from molecular biology to cardiopulmonary physiology |
| Q77485489 | Hypoxia-inducible factor 1: master regulator of O2 homeostasis |
| Q33217146 | Hypoxia-inducible factor modulates tubular cell survival in cisplatin nephrotoxicity |
| Q28569680 | Hypoxia-inducible factor-1 (HIF-1)-independent microvascular angiogenesis in the aged rat brain |
| Q38108833 | Hypoxia-inducible factor-1 (HIF-1): a potential target for intervention in ocular neovascular diseases |
| Q28303316 | Hypoxia-inducible factor-1 alpha is regulated at the post-mRNA level |
| Q36301943 | Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. |
| Q34768392 | Hypoxia-inducible factor-1alpha and the glycolytic phenotype in tumors. |
| Q30887474 | Hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression in circulating tumor cells of breast cancer patients. |
| Q83305663 | Hypoxia-inducible factor-1alpha expression requires PI 3-kinase activity and correlates with Akt1 phosphorylation in invasive breast carcinomas |
| Q44895076 | Hypoxia-inducible factor-1α (HIF-1α) potentiates β-cell survival after islet transplantation of human and mouse islets |
| Q38093246 | Hypoxia-inducible factor-1α as prognostic marker |
| Q33829094 | Hypoxia-inducible factor-2 is a novel regulator of aberrant CXCL12 expression in multiple myeloma plasma cells. |
| Q38352366 | Hypoxia-inducible protein binding to vascular endothelial growth factor mRNA and its modulation by the von Hippel-Lindau protein |
| Q37236104 | Hypoxia-ischemia and retinal ganglion cell damage |
| Q35170901 | Hypoxia-mediated mechanism of MUC5AC production in human nasal epithelia and its implication in rhinosinusitis. |
| Q33630415 | Hypoxia-mediated regulation of gene expression in mammalian cells |
| Q38337618 | Hypoxic induction of Ctgf is directly mediated by Hif-1. |
| Q35677277 | Hypoxic regulation of VEGF mRNA stability by RNA-binding proteins |
| Q40358322 | Hypoxic regulation of stability of connective tissue growth factor/CCN2 mRNA by 3'-untranslated region interacting with a cellular protein in human chondrosarcoma cells. |
| Q38610158 | Hypoxic regulation of vascular endothelial growth factor mRNA stability requires the cooperation of multiple RNA elements |
| Q38302671 | Identification and characterization of a low oxygen response element involved in the hypoxic induction of a family of Saccharomyces cerevisiae genes. Implications for the conservation of oxygen sensing in eukaryotes |
| Q42092346 | Identification of a functional hypoxia-responsive element that regulates the expression of the egl nine homologue 3 (egln3/phd3) gene |
| Q36857442 | Identification of a human VPF/VEGF 3' untranslated region mediating hypoxia-induced mRNA stability |
| Q24537185 | Identification of a novel hypoxia-inducible factor 1-responsive gene, RTP801, involved in apoptosis. |
| Q30891401 | Identification of an exonic splicing silencer in exon 6A of the human VEGF gene |
| Q58486019 | Identification of an oxygen responsive enhancer element in the glyceraldehyde-3-phosphate dehydrogenase gene |
| Q30664150 | Identification of hypoxia-responsive genes in a dopaminergic cell line by subtractive cDNA libraries and microarray analysis |
| Q48058964 | Identification of hypoxically inducible mRNAs in HeLa cells using differential-display PCR. Role of hypoxia-inducible factor-1. |
| Q33180622 | In vivo detection of human vascular endothelial growth factor promoter activity in transgenic mouse skin |
| Q35167228 | Incorporation of a prolyl hydroxylase inhibitor into scaffolds: a strategy for stimulating vascularization |
| Q51360163 | Increased hypoxia correlates with increased expression of the angiogenesis marker vascular endothelial growth factor in human prostate cancer. |
| Q36791642 | Induction of VEGFA mRNA translation by CoCl2 mediated by HuR. |
| Q35081587 | Induction of hypervascularity without leakage or inflammation in transgenic mice overexpressing hypoxia-inducible factor-1alpha |
| Q38138158 | Influence of inflammation on cardiovascular protective effects of cytochrome P450 epoxygenase-derived epoxyeicosatrienoic acids. |
| Q42625991 | Inhibition of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-stimulated Cyp1a1 promoter activity by hypoxic agents |
| Q38571725 | Inhibition of hypoxia inducible factor hydroxylases protects against renal ischemia-reperfusion injury |
| Q33186790 | Inhibition of hypoxia‐induced angiogenesis by cigarette smoke exposure: impairment of the HIF‐lalpha/VEGF pathway |
| Q22254113 | Inhibition of vascular endothelial growth factor expression in HEC1A endometrial cancer cells through interactions of estrogen receptor alpha and Sp3 proteins |
| Q38282792 | Inhibitory effect on expression of angiogenic factors by antiangiogenic agents in renal cell carcinoma |
| Q28573499 | Insulin activates hypoxia-inducible factor-1alpha in human and rat vascular smooth muscle cells via phosphatidylinositol-3 kinase and mitogen-activated protein kinase pathways: impairment in insulin resistance owing to defects in insulin signalling |
| Q40729554 | Insulin stimulates hypoxia-inducible factor 1 through a phosphatidylinositol 3-kinase/target of rapamycin-dependent signaling pathway |
| Q35102944 | Insulin-like growth factor-I plays a pathogenetic role in diabetic retinopathy |
| Q35877539 | Insulin-resistant subjects have normal angiogenic response to aerobic exercise training in skeletal muscle, but not in adipose tissue |
| Q38328631 | Internal translation initiation mediated by the angiogenic factor Tie2. |
| Q44006846 | Intramyocardial injection of naked DNA encoding HIF-1alpha/VP16 hybrid to enhance angiogenesis in an acute myocardial infarction model in the rat. |
| Q45224240 | Intravitreal injection of specific receptor tyrosine kinase inhibitor PTK787/ZK222 584 improves ischemia-induced retinopathy in mice |
| Q34086461 | Involvement of PLAGL2 in activation of iron deficient- and hypoxia-induced gene expression in mouse cell lines |
| Q40786643 | Involvement of p38 MAP kinase in TGF-beta-stimulated VEGF synthesis in aortic smooth muscle cells |
| Q39455739 | Isoforms of vascular endothelial growth factor act in a coordinate fashion To recruit and expand tumor vasculature. |
| Q44828166 | Key role of endothelial importin-α in VEGF expression and gastric angiogenesis: novel insight into aging gastropathy |
| Q51992598 | Kidney development and gene expression in the HIF2alpha knockout mouse. |
| Q38952702 | Limb ischemia and vessel regeneration: Is there a role for VEGF? |
| Q38997360 | Long-Term Effects of Prenatal Hypoxia on Schizophrenia-Like Phenotype in Heterozygous Reeler Mice. |
| Q47318335 | Low molecular weight fucoidan increases VEGF165-induced endothelial cell migration by enhancing VEGF165 binding to VEGFR-2 and NRP1. |
| Q41022521 | MCPIP1 contributes to clear cell renal cell carcinomas development |
| Q33368236 | Making (anti)sense of non-coding sequence conservation |
| Q41756447 | Mammalian oxygen sensing and hypoxia inducible factor-1. |
| Q51600069 | Management of dural arteriovenous fistulas - Helsinki and Kuopio experience. |
| Q35173866 | Many mechanisms mediating mobilization: an alliterative review |
| Q38584496 | Mechanical overload induces VEGF in cartilage discs via hypoxia-inducible factor |
| Q40875916 | Mechanism of transforming growth factor-beta1-induced expression of vascular endothelial growth factor in murine osteoblastic MC3T3-E1 cells |
| Q36800145 | Melatonin rescues cardiovascular dysfunction during hypoxic development in the chick embryo |
| Q35230207 | Methyl tert butyl ether targets developing vasculature in zebrafish (Danio rerio) embryos |
| Q36527578 | Methylation-dependent regulation of HIF-1α stability restricts retinal and tumour angiogenesis. |
| Q44060405 | Mimosine prevents the death of glucose-deprived immunostimulated astrocytes by scavenging peroxynitrite |
| Q37064874 | Mitochondrial complex III regulates hypoxic activation of HIF. |
| Q29614203 | Mitochondrial reactive oxygen species trigger hypoxia-induced transcription |
| Q35579264 | Mobilization of hematopoietic stem cells from the bone marrow niche to the blood compartment |
| Q43829177 | Modulation of inducible nitric oxide synthase by hypoxia in pulmonary artery endothelial cells |
| Q42121924 | Molecular and clinical aspects of targeting the VEGF pathway in tumors. |
| Q36474276 | Molecular aspects of tissue engineering in the dental field |
| Q24534053 | Molecular mechanisms of transcription activation by HLF and HIF1alpha in response to hypoxia: their stabilization and redox signal-induced interaction with CBP/p300. |
| Q32061166 | Mouse model of angiogenesis |
| Q33977693 | Multiple molecular penumbras after focal cerebral ischemia |
| Q28365260 | Mutant epidermal growth factor receptor enhances induction of vascular endothelial growth factor by hypoxia and insulin-like growth factor-1 via a PI3 kinase dependent pathway |
| Q37286026 | Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein |
| Q36163304 | New insight into the transcriptional regulation of vascular endothelial growth factor expression in the endometrium by estrogen and relaxin |
| Q41728414 | Nitric oxide synthase inhibition attenuates the skeletal muscle VEGF mRNA response to exercise |
| Q35052184 | Noninvasive MRI of endothelial cell response to human breast cancer cells. |
| Q42830848 | Nucleotide sequence of the mouse VEGF 3'UTR and quantitative analysis of sites of polyadenylation |
| Q79317980 | Obesity is associated with impaired coronary collateral vessel development |
| Q39642324 | Old proteins - new locations: myoglobin, haemoglobin, neuroglobin and cytoglobin in solid tumours and cancer cells. |
| Q30436403 | On aerobic exercise and behavioral and neural plasticity |
| Q36947046 | Oncogenic Ras and transforming growth factor-beta synergistically regulate AU-rich element-containing mRNAs during epithelial to mesenchymal transition. |
| Q37472214 | Osteogenic gene expression correlates with development of heterotopic ossification in war wounds. |
| Q49797908 | Oxygen Matters: Hypoxia as a Pathogenic Mechanism in Rhinosinusitis |
| Q41131100 | Oxygen regulated gene expression: erythropoietin as a model system |
| Q47684051 | Oxygen sensing and response to hypoxia by mammalian cells |
| Q36796826 | Oxygen supply and oxygen-dependent gene expression in differentiating embryonic stem cells |
| Q41131070 | Oxygen- and dioxin-regulated gene expression in mouse hepatoma cells |
| Q30468335 | PDGF/VEGF system activation and angiogenesis following initial post ovariectomy meningeal microvessel loss. |
| Q28383083 | PI3K/PTEN signaling in angiogenesis and tumorigenesis |
| Q42437368 | Parathyroid hormone-related protein interacts with vascular endothelial growth factor to promote fibrogenesis in the obstructed mouse kidney |
| Q33402040 | Phase I study of bevacizumab, everolimus, and panobinostat (LBH-589) in advanced solid tumors |
| Q36143404 | Phospholipid scramblase 1 is required for β2-glycoprotein I binding in hypoxia and reoxygenation-induced endothelial inflammation |
| Q34805548 | Placental vasculogenesis is regulated by keratin-mediated hyperoxia in murine decidual tissues |
| Q37210436 | Placental villous vascular endothelial growth factor expression and vascularization after estrogen suppression during the last two-thirds of baboon pregnancy |
| Q74153475 | Podokinesis in endothelial cell migration: role of nitric oxide |
| Q39941142 | Polymeric gene delivery of ischemia-inducible VEGF significantly attenuates infarct size and apoptosis following myocardial infarct. |
| Q45389036 | Polymorphisms of hypoxia-related genes in subjects susceptible to acute mountain sickness |
| Q44061379 | Population pharmacokinetics of pegaptanib in patients with neovascular, age-related macular degeneration |
| Q54668845 | Post-transcriptional regulation of VEGF expression by oxidised LDL in human macrophages. |
| Q54512826 | Post-transcriptional regulation of VEGF-A mRNA levels by mitogen-activated protein kinases (MAPKs) during metabolic stress associated with ischaemia/reperfusion. |
| Q37285776 | Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene |
| Q31152215 | Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema |
| Q90430825 | Postnatal development of cerebrovascular structure and the neurogliovascular unit |
| Q45194986 | Posttranscriptional regulation of the immediate-early gene EGR1 by light in the mouse retina |
| Q47180325 | Preservation of kidneys by machine perfusion influences gene expression and may limit ischemia/reperfusion injury |
| Q35787073 | Pro-inflammatory cytokines induce expression of matrix-metabolizing enzymes in human cervical smooth muscle cells |
| Q41015545 | Production of vascular endothelial growth factor by murine macrophages: regulation by hypoxia, lactate, and the inducible nitric oxide synthase pathway |
| Q48306652 | Prolonged hypoxia increases vascular endothelial growth factor mRNA and protein in adult mouse brain |
| Q40489176 | Prosurvival and prodeath effects of hypoxia-inducible factor-1alpha stabilization in a murine hippocampal cell line. |
| Q28376328 | Protection from oxidative stress-induced apoptosis in cortical neuronal cultures by iron chelators is associated with enhanced DNA binding of hypoxia-inducible factor-1 and ATF-1/CREB and increased expression of glycolytic enzymes, [...] |
| Q54286563 | Protective effects of astaxanthin on capillary regression in atrophied soleus muscle of rats. |
| Q24337730 | RKTG inhibits angiogenesis by suppressing MAPK-mediated autocrine VEGF signaling and is downregulated in clear-cell renal cell carcinoma |
| Q24796716 | Regional differences in expression of VEGF mRNA in rat gastrocnemius following 1 hr exercise or electrical stimulation |
| Q35146833 | Regression of established tumors and metastases by potent vascular endothelial growth factor blockade |
| Q35055667 | Regulated in development and DNA damage 1 is necessary for hyperglycemia-induced vascular endothelial growth factor expression in the retina of diabetic rodents |
| Q41129255 | Regulation of ATP synthase subunit e gene expression by hypoxia: cell differentiation stage-specific control |
| Q40550809 | Regulation of Drosophila hypoxia-inducible factor (HIF) activity in SL2 cells: identification of a hypoxia-induced variant isoform of the HIFalpha homolog gene similar. |
| Q40832375 | Regulation of an endogenous locus using a panel of designed zinc finger proteins targeted to accessible chromatin regions. Activation of vascular endothelial growth factor A. |
| Q40862222 | Regulation of endothelin-1 gene expression in human microvascular endothelial cells by hypoxia and cobalt: role of hypoxia responsive element |
| Q41667690 | Regulation of gene expression by hypoxia: a molecular approach |
| Q28293147 | Regulation of human vascular endothelial growth factor mRNA stability in hypoxia by heterogeneous nuclear ribonucleoprotein L |
| Q39946802 | Regulation of hypoxia-induced angiogenesis: a chaperone escorts VEGF to the dance |
| Q78251607 | Regulation of transforming growth factor-beta, basic fibroblast growth factor, and vascular endothelial cell growth factor mRNA in peripheral blood leukocytes in patients with diabetic retinopathy |
| Q41131062 | Regulation of vascular endothelial growth factor by hypoxia and its modulation by the von Hippel-Lindau tumor suppressor gene |
| Q38296576 | Regulation of vascular endothelial growth factor expression by advanced glycation end products |
| Q36620509 | Regulation of vascular endothelial growth factor expression in human colon cancer by interleukin-1beta |
| Q51595101 | Regulators of the hypoxic response: a growing family. |
| Q35739660 | Relationship between vitreous and serum vascular endothelial growth factor levels, control of diabetes and microalbuminuria in proliferative diabetic retinopathy |
| Q42526028 | Role of components of the phagocytic NADPH oxidase in oxygen sensing |
| Q22253951 | Role of hypoxia-inducible factor-1 in transcriptional activation of ceruloplasmin by iron deficiency |
| Q36919959 | Role of the retinal vascular endothelial cell in ocular disease |
| Q35300661 | Role of vascular permeability factor/vascular endothelial growth factor in eye disease |
| Q33616384 | Roles of vascular endothelial growth factor in amyotrophic lateral sclerosis |
| Q34206194 | SSeCKS regulates angiogenesis and tight junction formation in blood-brain barrier |
| Q48049530 | Sequencing of the human vascular endothelial growth factor (VEGF) 3' untranslated region (UTR): conservation of five hypoxia-inducible RNA-protein binding sites |
| Q48545238 | Serum VEGF levels in acute ischaemic strokes are correlated with long-term prognosis |
| Q34047250 | Signaling angiogenesis via p42/p44 MAP kinase and hypoxia |
| Q37301035 | Signaling hypoxia by hypoxia-inducible factor protein hydroxylases: a historical overview and future perspectives |
| Q28267232 | Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha |
| Q78836958 | Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis |
| Q73420775 | Stimulation of GATA-2 as a mechanism of hydrogen peroxide suppression in hypoxia-induced erythropoietin gene expression |
| Q43862692 | Stimulation of vascular endothelial growth factor gene transcription by all trans retinoic acid through Sp1 and Sp3 sites in human bronchioloalveolar carcinoma cells |
| Q52167716 | Stress-activated protein kinases (JNK and p38/HOG) are essential for vascular endothelial growth factor mRNA stability. |
| Q37369310 | Stretch-induced VEGF expression in the heart |
| Q41347443 | Structural and functional analysis of hypoxia-inducible factor 1. |
| Q37581083 | Suppression of Akt-HIF-1α signaling axis by diacetyl atractylodiol inhibits hypoxia-induced angiogenesis |
| Q33345135 | Suppression of extravillous trophoblast vascular endothelial growth factor expression and uterine spiral artery invasion by estrogen during early baboon pregnancy |
| Q35545269 | Synergistic up-regulation of vascular endothelial growth factor (VEGF) expression in macrophages by adenosine A2A receptor agonists and endotoxin involves transcriptional regulation via the hypoxia response element in the VEGF promoter |
| Q35747988 | Synergistic up-regulation of vascular endothelial growth factor expression in murine macrophages by adenosine A(2A) receptor agonists and endotoxin |
| Q93090713 | Systemic Factors Trigger Vasculature Cells to Drive Notch Signaling and Neurogenesis in Neural Stem Cells in the Adult Brain |
| Q33615441 | Systemic hypoxia changes the organ-specific distribution of vascular endothelial growth factor and its receptors |
| Q43968903 | TAp63gamma (p51A) and dNp63alpha (p73L), two major isoforms of the p63 gene, exert opposite effects on the vascular endothelial growth factor (VEGF) gene expression. |
| Q28568288 | TGF-beta repression of Id2 induces apoptosis in gut epithelial cells |
| Q37387690 | TNFalpha induces HIF-1alpha expression through activation of IKKbeta |
| Q57377984 | Targeting gene expression to hypoxic tumor cells |
| Q48027284 | The Elongin BC complex and the von Hippel-Lindau tumor suppressor protein |
| Q36174569 | The HO-1/CO system regulates mitochondrial-capillary density relationships in human skeletal muscle |
| Q64916902 | The L-Type Amino Acid Transporter LAT1-An Emerging Target in Cancer. |
| Q28266392 | The RNA binding protein Zfp36l1 is required for normal vascularisation and post-transcriptionally regulates VEGF expression |
| Q28077024 | The Role of CC-Chemokines in the Regulation of Angiogenesis |
| Q53668097 | The Wilms' tumour suppressor Wt1 is a major regulator of tumour angiogenesis and progression. |
| Q50933010 | The angiopoietin pathway is modulated by PAR-1 activation on human endothelial progenitor cells. |
| Q46178046 | The axon guidance molecule Netrin-4 is expressed by Müller cells and contributes to angiogenesis in the retina |
| Q33933167 | The biochemical and physiological characteristics of receptors |
| Q44317160 | The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency |
| Q42825086 | The effect of hypoxia mimetic cobalt chloride on the expression of EC-SOD in 3T3-L1 adipocytes |
| Q52141308 | The expression of transforming growth factor-beta1 is significantly correlated with the expression of vascular endothelial growth factor and poor prognosis of patients with advanced gastric carcinoma. |
| Q73327904 | The function of hypoxia-inducible factor 1 (HIF-1) is impaired in senescent mice |
| Q34425462 | The hemostatic system and angiogenesis in malignancy. |
| Q41110054 | The mouse gene for hypoxia-inducible factor-1alpha--genomic organization, expression and characterization of an alternative first exon and 5' flanking sequence |
| Q39255648 | The novel tumor suppressor NOL7 post-transcriptionally regulates thrombospondin-1 expression. |
| Q34658478 | The pathogenesis of diabetic retinopathy: old concepts and new questions |
| Q45004021 | The potential role of hypoxia inducible factor 1alpha in tumor progression after hypoxia and chemotherapy in hepatocellular carcinoma |
| Q34324270 | The regulation of hypoxic genes by calcium involves c-Jun/AP-1, which cooperates with hypoxia-inducible factor 1 in response to hypoxia |
| Q28728051 | The related transcriptional enhancer factor-1 isoform, TEAD4(216), can repress vascular endothelial growth factor expression in mammalian cells |
| Q39036151 | The role of endoglin in post-ischemic revascularization. |
| Q37478093 | The role of hypoxia in 2-butoxyethanol-induced hemangiosarcoma. |
| Q38154615 | The role of hypoxia in stem cell potency and differentiation |
| Q92360633 | The role of hypoxia-inducible factors in neovascular age-related macular degeneration: a gene therapy perspective |
| Q93259182 | The role of mitochondria in angiogenesis |
| Q38356370 | The role of the aryl hydrocarbon receptor nuclear translocator (ARNT) in hypoxic induction of gene expression. Studies in ARNT-deficient cells |
| Q33997842 | The role of the vascular phase in solid tumor growth: a historical review |
| Q37308157 | The role of vascular endothelial growth factor in wound healing |
| Q46468770 | The role of vascular endothelial growth factor in wound healing |
| Q34779815 | The transcription factors ATF-1 and CREB-1 bind constitutively to the hypoxia-inducible factor-1 (HIF-1) DNA recognition site |
| Q36627750 | The tumor microenvironment: key to early detection |
| Q33813039 | The ubiquitin ligase Siah2 and the hypoxia response |
| Q33737967 | The vascular endothelial growth factor family: signalling for vascular development. |
| Q35036600 | The von Hippel-Lindau tumor suppressor, hypoxia-inducible factor-1 (HIF-1) degradation, and cancer pathogenesis. |
| Q37961586 | Therapeutic angiogenesis for myocardial ischemia revisited: basic biological concepts and focus on latest clinical trials. |
| Q35847620 | Thrombopoietin enhances expression of vascular endothelial growth factor (VEGF) in primitive hematopoietic cells through induction of HIF-1alpha |
| Q33851340 | Toll-like receptor 4 in inflammation and angiogenesis: a double-edged sword |
| Q37885347 | Towards novel radiosensitizing agents: the role of cytosolic PLA2α in combined modality cancer therapy |
| Q34390790 | Transduction pathways involved in Hypoxia-Inducible Factor-1 phosphorylation and activation |
| Q42562736 | Transforming growth factor-beta 1 (TGF-beta1) induces angiogenesis through vascular endothelial growth factor (VEGF)-mediated apoptosis |
| Q42525192 | Transient hypoxia stimulates mitochondrial biogenesis in brain subcortex by a neuronal nitric oxide synthase-dependent mechanism. |
| Q40895017 | Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck |
| Q24522773 | Two independent internal ribosome entry sites are involved in translation initiation of vascular endothelial growth factor mRNA |
| Q38196317 | Unwrapping the origins and roles of the renal endothelium. |
| Q30437625 | Up-regulation of hypoxia-inducible factor 1 alpha and hemodynamic responses following massive small bowel resection |
| Q37642798 | Update on novel agents in renal cell carcinoma |
| Q74413959 | Upregulation of vascular endothelial growth factor by angiotensin II in rat heart endothelial cells |
| Q34932327 | VEGF and the quest for tumour angiogenesis factors |
| Q36319029 | VEGF as a therapeutic target in cancer |
| Q37598929 | VEGF as an inhibitor of tumor vessel maturation: implications for cancer therapy |
| Q35745892 | VEGF expression by epithelial and stromal cell compartments: resolving a controversy |
| Q40324140 | VEGF gene expression is regulated post-transcriptionally in macrophages |
| Q42805271 | VEGF mRNA is stabilized by ras and tyrosine kinase oncogenes, as well as by UV radiation--evidence for divergent stabilization pathways |
| Q34355786 | VEGF neutralizing antibody increases the therapeutic efficacy of vinorelbine for renal cell carcinoma |
| Q37197773 | VEGF-A mRNA processing, stability and translation: a paradigm for intricate regulation of gene expression at the post-transcriptional level |
| Q34733006 | VEGF/VEGFR2 and PDGF-B/PDGFR-β expression in non-metastatic renal cell carcinoma: a retrospective study in 1,091 consecutive patients |
| Q36949564 | VEGF: an essential mediator of both angiogenesis and endochondral ossification |
| Q36256103 | Variable incidence of cyclosporine and FK-506 neurotoxicity in hematopoeitic malignancies and marrow conditions after allogeneic bone marrow transplantation |
| Q34691790 | Vascular Endothelial Growth Factor -460 C/T BstUI Gene Polymorphism is associated with Primary Open Angle Glaucoma |
| Q73129419 | Vascular endothelial growth factor |
| Q71910454 | Vascular endothelial growth factor and its receptors |
| Q35919917 | Vascular endothelial growth factor and the nervous system. |
| Q35607191 | Vascular endothelial growth factor antagonist modulates leukocyte trafficking and protects mouse livers against ischemia/reperfusion injury |
| Q37621018 | Vascular endothelial growth factor controls neuronal migration and cooperates with Sema3A to pattern distinct compartments of the facial nerve |
| Q46370122 | Vascular endothelial growth factor expression and cyclosporine toxicity in renal allograft rejection |
| Q36621192 | Vascular endothelial growth factor expression is independent of hypoxia in human malignant glioma spheroids and tumours |
| Q40550921 | Vascular endothelial growth factor expression promotes the growth of breast cancer brain metastases in nude mice |
| Q44077053 | Vascular endothelial growth factor gene expression in a retinal pigmented cell is up-regulated by glucose deprivation through 3' UTR. |
| Q46389653 | Vascular endothelial growth factor gene expression in middle cerebral artery occlusion in the rat. |
| Q44622583 | Vascular endothelial growth factor rescues 2,3,7,8‐tetrachlorodibenzo‐p‐dioxin inhibition of coronary vasculogenesis |
| Q73368035 | Vascular endothelial growth factor upregulation in transient global ischemia induced by cardiac arrest and resuscitation in rat brain |
| Q57382287 | Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells |
| Q35842072 | Vascular repair after menstruation involves regulation of vascular endothelial growth factor-receptor phosphorylation by sFLT-1. |
| Q47674378 | Vascular-specific growth factor mRNA levels in the human diaphragm |
| Q24313128 | Vasoactive peptides modulate vascular endothelial cell growth factor production and endothelial cell proliferation and invasion |
| Q27028225 | Vitreous mediators in retinal hypoxic diseases |
| Q48152994 | Voluntary Physical Exercise Induces Expression and Epigenetic Remodeling of VegfA in the Rat Hippocampus |
| Q42373787 | William Kaelin, Peter Ratcliffe, and Gregg Semenza receive the 2016 Albert Lasker Basic Medical Research Award. |
| Q79972183 | [Fetal wound healing: current status and new perspectives] |
| Q77388861 | [Oxygenation status of squamous cell carcinoma of the head and neck: comparison of primary tumors, their neck node metastases and normal tissue] |
Search more.